Found 42 matching trials
Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors PHASE1 This phase I trial is studying the side effects of decitabine when given to...
Show More Location
Nevada Cancer Institute-Summerlin Campus
Learn More & Join Trial
Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL PHASE2 This study is to determine the response to acalabrutinib in patients with c...
Show More Learn More & Join Trial
Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation PHASE1 This study is a randomized, double-blind, placebo-controlled I/II clinical ...
Show More Location
Jiangsu Provincal Center for Disease Control and Prevention
Learn More & Join Trial
A Study to Assess the Safety of MEB-1170 in Healthy Subjects PHASE1 Primary Objective: To determine the safety and tolerability of single and m...
Show More Location
Labcorp Clinical Research Unit, Inc
Learn More & Join Trial
Pilot Study of IFN α2b for Melanoma Patients EARLY_PHASE1 The presence of malignant cells in lymph nodes is a critical parameter in t...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C PHASE1 The purpose of this study is to assess the safety, pharmacokinetics, HCV RN...
Show More Location
Toranomon Hospital
Learn More & Join Trial
Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma PHASE1 This phase I trial is studying the side effects and best dose of interleuki...
Show More Location
Cleveland Clinic Taussig Cancer Center
Learn More & Join Trial
A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma PHASE2 Participants will have a diagnosis of dedifferentiated liposarcoma (DDLS) t...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy PHASE3 HRN-003 STUDY SYNOPSIS
OBJECTIVE: To compare the Sustained Virologic Respo...
Show More Location
Johns Hopkins Univesity School of Medicine
Learn More & Join Trial
Modified Vaccine for High Risk or Low Residual Melanoma Patients PHASE1 This study is designed for patients who had malignant melanoma and, followi...
Show More Location
Sharett Institute of Oncology, Hadassah Medical Organization
Learn More & Join Trial